WallStSmart

Chemours Co (CC)vsSherwin-Williams Co (SHW)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Sherwin-Williams Co generates 321% more annual revenue ($24.41B vs $5.80B). SHW leads profitability with a 11.0% profit margin vs -5.2%. CC appears more attractively valued with a PEG of 1.60. SHW earns a higher WallStSmart Score of 60/100 (C+).

CC

Avoid

35

out of 100

Grade: F

Growth: 2.0Profit: 3.0Value: 3.7Quality: 6.0
Piotroski: 3/9Altman Z: 1.25

SHW

Buy

60

out of 100

Grade: C+

Growth: 5.3Profit: 8.0Value: 5.3Quality: 4.0
Piotroski: 4/9Altman Z: 1.54
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CCSignificantly Overvalued (-22.2%)

Margin of Safety

-22.2%

Fair Value

$17.20

Current Price

$15.03

$2.17 premium

UndervaluedFair: $17.20Overvalued
SHWUndervalued (+2.3%)

Margin of Safety

+2.3%

Fair Value

$330.90

Current Price

$324.50

$6.40 discount

UndervaluedFair: $330.90Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CC1 strengths · Avg: 10.0/10
Debt/EquityHealth
-84.0810/10

Conservative balance sheet, low leverage

SHW3 strengths · Avg: 9.0/10
Return on EquityProfitability
69.7%10/10

Every $100 of equity generates 70 in profit

Market CapQuality
$78.49B9/10

Large-cap with strong market position

Free Cash FlowQuality
$1.24B8/10

Generating 1.2B in free cash flow

Areas to Watch

CC4 concerns · Avg: 3.0/10
PEG RatioValuation
1.604/10

Expensive relative to growth rate

Operating MarginProfitability
1.1%3/10

Operating margin of 1.1%

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-103.0%2/10

ROE of -103.0% — below average capital efficiency

SHW4 concerns · Avg: 3.5/10
PEG RatioValuation
2.054/10

Expensive relative to growth rate

P/E RatioValuation
29.3x4/10

Moderate valuation

Altman Z-ScoreHealth
1.544/10

Distress zone — elevated risk

Price/BookValuation
20.3x2/10

Trading at 20.3x book value

Comparative Analysis Report

WallStSmart Research

Bull Case : CC

The strongest argument for CC centers on Debt/Equity.

Bull Case : SHW

The strongest argument for SHW centers on Return on Equity, Market Cap, Free Cash Flow.

Bear Case : CC

The primary concerns for CC are PEG Ratio, Operating Margin, Piotroski F-Score.

Bear Case : SHW

The primary concerns for SHW are PEG Ratio, P/E Ratio, Altman Z-Score. Debt-to-equity of 3.69 is elevated, increasing financial risk.

Key Dynamics to Monitor

CC profiles as a turnaround stock while SHW is a value play — different risk/reward profiles.

CC carries more volatility with a beta of 1.42 — expect wider price swings.

SHW is growing revenue faster at 7.5% — sustainability is the question.

SHW generates stronger free cash flow (1.2B), providing more financial flexibility.

Bottom Line

SHW scores higher overall (60/100 vs 35/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Chemours Co

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

The Chemours Company offers high performance chemicals in North America, Asia Pacific, Europe, the Middle East, Africa and Latin America. The company is headquartered in Wilmington, Delaware.

Sherwin-Williams Co

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Sherwin Williams Company is a Cleveland, Ohio based company in the paint and coating manufacturing industry. The company primarily engages in the manufacture, distribution, and sale of paints, coatings, floorcoverings, and related products to professional, industrial, commercial, and retail customers primarily in North and South America and Europe.

Want to dig deeper into these stocks?